Statement From TGA
Statement from The Therapeutic Goods Administration relating to the story on breast implants
The Therapeutic Goods Administration (TGA) is aware of recent decisions taken by international regulators in relation to polyurethane-coated and macro-textured breast implants.
It has sought additional clarification from these regulators and has convened an urgent meeting of its breast implant expert working group to consider the most recent actions of regulators and any additional evidence available.
The safety and confidence of women is at the forefront of our considerations.
The TGA will publish a position statement following consideration of the views of the expert working group and a review of other information available to the TGA.